Abstract
Botulinum toxin (BTX), a potent neurotoxin which is produced by the bacterium Clostridium botulinum, consists of eight distinct neurotoxin serotypes referred to as (BTX type‑A [BTX‑A], B, C, D, E, F, G, H) all of which inhibit acetylcholine release at the neuromuscular junction. BTX‑A, by blocking acetylcholine release at neuromuscular junctions, accounts for its therapeutic action to relieve dystonia, spasticity, and related disorders. A wide variety of medical conditions such as bruxism, hyperhidrosis, achalasia,focal dystonia, upper motor neuron syndrome, blepharospasm, and chronic migraine are now treated with BTX. The cosmetological applications include correction of lines, creases, and wrinkling all over the face, chin, neck, and chest. Side effects are generally rare and minimal. Injections with BTX‑A are well‑tolerated. Discovery of further newer indications of this neurotoxin can enlighten the path of research in the field of neuroscience. Key words: Botulinum toxin, cosmetic uses, neurotoxin
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
